Review article · 2005 · Open access
Factors influencing inclusion of patients with malignancies in clinical trials: A review
Cancer, 106(2), 258–270 · Published 7 December 2005 · DOI 10.1002/cncr.21613
In brief
“Factors influencing inclusion of patients with malignancies in clinical trials: A review” is a 2005 review article by Caroline Tournoux and 3 co-authors, published in Cancer. OpenAlex counts 94 citations as of 22 November 2026. It is open access: the full text is free to read at Cancer.
- Citations
- 94
- Most cited in
- 2017 (7)
- Field-weighted impact
- 0.80
- References
- 84
- Authors
- 4
Abstract
Participation in clinical trials remains low and is a central issue in oncology. The authors identified, through a systematic review, 75 papers published up to August 2004 that report barriers to recruitment of patients in clinical trials. These barriers range from patient preference and concern about information/consent to clinical problems with protocols. Strategies to overcome barriers on the part of patients and clinicians are needed and should be carefully evaluated. Thirty-three (44%) papers reported factors related to patients as influencing the inclusion of patients, 28 (37%) reported clinician's related factors, and 37 (49%) other factors from either specific groups of patients (30 papers, 40%) and/or other scopes (13 papers, 17%). No differences in prevalence were found between papers dedicated to hematologic malignancies and solid tumors. Factors related to clinicians as influential were more frequently reported before 1995 (70%) than thereafter (25%; P = 0.0009). Reporting specific groups of patients as influential was more frequent in North American articles (50%) than in others (14%, P = 0.008). Patients' barriers included mostly patient preference (12 papers), concern about information and/or consent (11 papers), worry about uncertainty (7 papers), and/or relationship with medical team (7 papers). Concerning clinicians, incompatibility of protocol with normal practice (nine papers), problems in complying with the protocol (eight papers), and/or consent procedure (eight papers) were the most reported factors. The remaining factors mostly relied on specific groups of patients (30 papers), notably age of patients (18 papers) and/or minority population (11 papers, all from the USA). Strategies to overcome these barriers are needed and should be carefully evaluated.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Tournoux, C., Katsahian, S., Chevret, S., & Lévy, V. (2005). Factors influencing inclusion of patients with malignancies in clinical trials: A review. Cancer, 106(2), 258–270. https://doi.org/10.1002/cncr.21613
MLA 9
Tournoux, Caroline, et al. “Factors influencing inclusion of patients with malignancies in clinical trials: A review.” Cancer, vol. 106, no. 2, 2005, pp. 258–270. https://doi.org/10.1002/cncr.21613.
Chicago
Tournoux, Caroline, Sandrine Katsahian, Sylvie Chevret, and Vincent Lévy. 2005. “Factors influencing inclusion of patients with malignancies in clinical trials: A review.” Cancer 106 (2): 258–270. https://doi.org/10.1002/cncr.21613.
Harvard
Tournoux, C. et al. (2005) ‘Factors influencing inclusion of patients with malignancies in clinical trials: A review’, Cancer, 106(2), pp. 258–270. doi:10.1002/cncr.21613.
IEEE
C. Tournoux, S. Katsahian, S. Chevret, and V. Lévy, “Factors influencing inclusion of patients with malignancies in clinical trials: A review,” Cancer, vol. 106, no. 2, pp. 258–270, 2005, doi: 10.1002/cncr.21613.
BibTeX
@article{tournoux2005factors,
title = {{Factors influencing inclusion of patients with malignancies in clinical trials: A review}},
author = {Tournoux, Caroline and Katsahian, Sandrine and Chevret, Sylvie and Lévy, Vincent},
journal = {Cancer},
year = {2005},
volume = {106},
number = {2},
pages = {258--270},
doi = {10.1002/cncr.21613},
url = {https://doi.org/10.1002/cncr.21613}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2016 | 4 | |
| 2017 | 7 | |
| 2018 | 6 | |
| 2019 | 6 | |
| 2020 | 6 | |
| 2021 | 2 | |
| 2022 | 2 | |
| 2023 | 1 | |
| 2024 | 1 | |
| 2026 | 1 |
Its field-weighted citation impact is 0.80: it has been cited 0.80 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- clinical trial recruitment
- barriers to participation
- patient inclusion
- cancer clinical trials
- patient preferences
- informed consent
- protocol adherence
- clinician factors
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Tournoux, C., Katsahian, S., Chevret, S., & Lévy, V. (2005). Factors influencing inclusion of patients with malignancies in clinical trials: A review. Cancer, 106(2), 258–270. https://doi.org/10.1002/cncr.21613
How many times has this paper been cited?
94 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Cancer: sign in and open the PDF from this page.
Who wrote this paper?
Caroline Tournoux, Sandrine Katsahian, Sylvie Chevret, Vincent Lévy.
What is the DOI of this paper?
10.1002/cncr.21613, permanently at https://doi.org/10.1002/cncr.21613. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.